Atlas Trials

Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer

Clinical trial NCT02481830 · COMPLETED

Trial details

NCT number
NCT02481830
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Lung Cancer
Start date
2015-09-14
Primary completion
2018-08-17
Enrollment
569

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.